1. Home
  2. MAGN vs EVMN Comparison

MAGN vs EVMN Comparison

Compare MAGN & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$12.00

Market Cap

448.6M

ML Signal

HOLD

Logo Evommune Inc.

EVMN

Evommune Inc.

HOLD

Current Price

$14.25

Market Cap

405.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAGN
EVMN
Founded
1864
2020
Country
United States
United States
Employees
2980
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.6M
405.2M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
MAGN
EVMN
Price
$12.00
$14.25
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$12.00
$43.88
AVG Volume (30 Days)
436.6K
500.5K
Earning Date
05-07-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
7.64
75.23
EPS
N/A
N/A
Revenue
$3,204,000,000.00
$13,000,000.00
Revenue This Year
$5.37
N/A
Revenue Next Year
$3.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.50
85.71
52 Week Low
$7.82
$10.47
52 Week High
$15.52
$33.20

Technical Indicators

Market Signals
Indicator
MAGN
EVMN
Relative Strength Index (RSI) 39.66 55.64
Support Level $11.55 $13.89
Resistance Level $15.03 $18.70
Average True Range (ATR) 0.60 0.71
MACD -0.20 0.51
Stochastic Oscillator 12.71 89.85

Price Performance

Historical Comparison
MAGN
EVMN

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: